.

.


The information on this site is from academic and research studies. Applicability to humans must be determined by a licensed medical professional.

Partial list of Citations used for Recommendations or Conditions

Recent additions may not be included. There is an intentional delay in making those available.

  1. In vitro susceptibility of anaerobic bacteria to nitroimidazoles.
    Scandinavian journal of infectious diseases. Supplementum (Scand J Infect Dis Suppl ) Vol: 26 Issue Pages: 42-5
    Pub: 1981 Epub:
    • Olsson-Liljequist B
    • Nord CE

  2. [In vitro sensitivity at 18 antibiotics of 192 strains of Pseudomonas aeruginosa isolated at Garches Hospital].
    Pathologie-biologie (Pathol Biol (Paris) ) Vol: 35 Issue 5 Pages: 558-62
    Pub: 1987 May Epub:
    • Ronco E
    • Vacheron F
    • Orabona A

  3. Minocycline as A Substitute for Doxycycline in Targeted Scenarios: A Systematic Review.
    Open forum infectious diseases (Open Forum Infect Dis ) Vol: 2 Issue 4 Pages: ofv178
    Pub: 2015 Dec Epub: 2015 Nov 25
    • Carris NW
    • Pardo J
    • Montero J
    • Shaeer KM

  4. Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases (Clin Microbiol Infect ) Vol: 20 Issue 12 Pages: O1075-83
    Pub: 2014 Dec Epub: 2014 Aug 11
    • Pericas JM
    • Cervera C
    • del Rio A
    • Moreno A
    • Garcia de la Maria C
    • Almela M
    • Falces C
    • Ninot S
    • Castañeda X
    • Armero Y
    • Soy D
    • Gatell JM
    • Marco F
    • Mestres CA
    • Miro JM
    • Hospital Clinic Endocarditis Study Group.

  5. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity.
    Journal of hepatology (J Hepatol ) Vol: 60 Issue 4 Pages: 824-31
    Pub: 2014 Apr Epub: 2013 Dec 6
    • Vrieze A
    • Out C
    • Fuentes S
    • Jonker L
    • Reuling I
    • Kootte RS
    • van Nood E
    • Holleman F
    • Knaapen M
    • Romijn JA
    • Soeters MR
    • Blaak EE
    • Dallinga-Thie GM
    • Reijnders D
    • Ackermans MT
    • Serlie MJ
    • Knop FK
    • Holst JJ
    • van der Ley C
    • Kema IP
    • Zoetendal EG
    • de Vos WM
    • Hoekstra JB
    • Stroes ES
    • Groen AK
    • Nieuwdorp M

  6. Bacteria is specified on label
    Manufacturer Label (Package Label ) Vol: Ingrediants Issue Current Pages: 0
    Pub: n/a Epub:

  7. Collateral damage from oral ciprofloxacin versus nitrofurantoin in outpatients with urinary tract infections: a culture-free analysis of gut microbiota.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases (Clin Microbiol Infect ) Vol: 21 Issue 4 Pages: 344.e1-11
    Pub: 2015 Apr Epub: 2014 Nov 25
    • Stewardson AJ
    • Gaïa N
    • François P
    • Malhotra-Kumar S
    • Delémont C
    • Martinez de Tejada B
    • Schrenzel J
    • Harbarth S
    • Lazarevic V
    • SATURN WP1 and WP3 Study Groups.

  8. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity.
    Journal of hepatology (J Hepatol ) Vol: 60 Issue 4 Pages: 824-31
    Pub: 2014 Apr Epub: 2013 Dec 6
    • Vrieze A
    • Out C
    • Fuentes S
    • Jonker L
    • Reuling I
    • Kootte RS
    • van Nood E
    • Holleman F
    • Knaapen M
    • Romijn JA
    • Soeters MR
    • Blaak EE
    • Dallinga-Thie GM
    • Reijnders D
    • Ackermans MT
    • Serlie MJ
    • Knop FK
    • Holst JJ
    • van der Ley C
    • Kema IP
    • Zoetendal EG
    • de Vos WM
    • Hoekstra JB
    • Stroes ES
    • Groen AK
    • Nieuwdorp M

  9. A single early-in-life macrolide course has lasting effects on murine microbial network topology and immunity
    Nature Communications (Nat Commun ) Vol: 8 Issue Pages: 518
    Pub: 2017 Sep 11 Epub: 2017 Sep 11
    • Ruiz VE
    • Battaglia T
    • Kurtz ZD
    • Bijnens L
    • Ou A
    • Engstrand I
    • Zheng X
    • Iizumi T
    • Mullins BJ
    • Müller CL
    • Cadwell K
    • Bonneau R
    • Perez-Perez GI
    • Blaser MJ

  10. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
    Antimicrobial agents and chemotherapy (Antimicrob Agents Chemother ) Vol: 17 Issue 2 Pages: 273-9
    Pub: 1980 Feb Epub:
    • Hall WH
    • Opfer BJ
    • Gerding DN

Full list available by paid subscriptions

For More information see this summary.